New FDA-Approved Treatment: Keytruda With Chemotherapy
December 12, 2024
Time: 8:00 p.m. ET
Discover how the new FDA-approved combination of Keytruda and chemotherapy will impact mesothelioma treatment during our upcoming webinar exclusively for patients and families. Hear from two mesothelioma experts about the efficacy of this groundbreaking treatment, potential side effects and what patients can expect.
Discover how the new FDA-approved combination of Keytruda and chemotherapy will impact mesothelioma treatment during our upcoming webinar exclusively for patients and families. Hear from two mesothelioma experts about the efficacy of this groundbreaking treatment, potential side effects and what patients can expect.
-
Dr. Catherine Perrault, DOFamily Physician and Patient Advocate -
Karen Selby, RNRegistered Nurse and Board Certified Patient Advocate -
Walter PachecoManaging Editor
What You’ll Learn During the Webinar
- Overview of current treatments and challenges in late-stage mesothelioma
- FDA approval of Keytruda with chemotherapy and what it means for mesothelioma treatment
- How Keytruda works in immunotherapy to fight mesothelioma
- Key clinical trial results, including survival rates and patient outcomes
- Expectations for patients during this treatment process
- Common side effects and ways to manage them
- Patient eligibility factors and things to consider
At the end of the presentation, our panelists will answer your questions during a live Q&A session.
Hear From Top Mesothelioma Experts
Registered nurse Karen Selby, family physician Dr. Catherine Perrault, and medical outreach director Missy Miller are committed to helping patients understand the resources and treatment options available to guide them through their journey with mesothelioma.-
Dr. Catherine Perrault, DODr. Catherine Perrault is a family physician, former U.S. Navy medical officer and Patient Advocate with The Mesothelioma Center. During her time as a shipboard medical officer, Dr. Perrault was responsible for screening asbestos removal teams and ensuring their safety. She is dedicated to providing a collaborative, open approach with patients to help them make informed decisions about their care. -
Karen Selby, RNKaren Selby is a registered nurse and Board Certified Patient Advocate at The Mesothelioma Center. For 15 years, she has supported mesothelioma patients and their families through every step of their journey, leveraging her extensive background in oncology and thoracic surgery. She is passionate about recognizing each patient’s unique needs and helping them access the tools they need to fight this rare cancer. -
Walter PachecoWith over 20 years of experience as an award-winning journalist, Walter Pacheco works as the managing editor for Asbestos.com. He and his dedicated team of writers support mesothelioma patients and their families with comprehensive articles about treatment innovations, clinical trials, top mesothelioma specialists and more. He is committed to providing valuable information about mesothelioma and asbestos for every stage of a patient's journey.
